MedPath

Brief Intervention Study for Quitting Smoking

Not Applicable
Terminated
Conditions
Smoking
Tobacco Use Cessation
Smoking Cessation
Interventions
Behavioral: Brief advice
Behavioral: Compact cessation course
Behavioral: Standard cessation course
Registration Number
NCT01589211
Lead Sponsor
Heidelberg University
Brief Summary

To investigate the effectiveness of a smoking cessation intervention of two sessions (120 min at a time) in a group setting on the basis of Motivational Interviewing (MI) and important elements of Cognitive Behavioural Therapy (CBT). According to national and international guidelines patients are advised to quit and pharmacologically supported with one of the established first line smoking cessation treatments.

Detailed Description

The study design is multicentric, prospective, randomized and controlled. The study is taking place in cooperation with smoking clinics of 5 centres in Germany (Heidelberg, Stuttgart, Munich, Chemnitz, Berlin). A total number of 800 smokers is calculated to participate in the study. After enrollment participants are randomized in one of the three intervention groups: (A) "Advice only", (B) "Brief intervention", (C) "Intensive therapy". The follow up includes a telephone interview 3 months after the last intervention, and two visits at the smoking clinics after 6 and 12 months with biochemical validation of the smoking status by measurement of the exhaled carbon monoxide and the concentration of cotinine in an urine sample respectively. The primary endpoint is the continuous abstinence rate after 12 months. Several secondary endpoints are determined amongst others the continuous abstinence rate after 6 months, point prevalence cessation rates after 6 and 12 months, life quality, weight gain, predictors of a successful cessation attempt.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
347
Inclusion Criteria
  • Smoker
  • Age > 18 years
  • Motivation to quit smoking
Exclusion Criteria
  • severe somatic comorbidity or reduced life expectancy
  • severe episode of a psychiatric disease
  • reduced cognitive ability
  • abuse of alcohol or illicit drugs
  • other reasons at the discretion of responsible local study tutor

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Brief adviceBrief adviceA brief advice to stop smoking of about 10 min accompanied with self-help material
Compact cessation courseCompact cessation courseCessation intervention of 2 x 120 min in a group setting
Standard cessation courseStandard cessation courseCessation course in a group setting over 6 dates
Primary Outcome Measures
NameTimeMethod
Continuous abstinence rate12 months

Biochemical validation by measurement of urine cotinine levels

Secondary Outcome Measures
NameTimeMethod
Continuous abstinence rate6 months
Depression0, 6 and 12 months
Time point abstinence rate6 and 12 months
Quality of life (SF36 short form)0, 6 and 12 months

Quality of life

Trial Locations

Locations (5)

Pneumologische Praxis im Zentrum (former: Zentrum für Tabakentwöhnung Stuttgart)

🇩🇪

Stuttgart, Baden-Württemberg, Germany

Institut für Raucherberatung und Tabakentwöhnung am Gemeinsschaftskrankenhaus Havelhöhe

🇩🇪

Berlin, Germany

Klinikum der Universität München - Klinik für Psychiatrie und Psychotherapie

🇩🇪

Munich, Bavaria, Germany

Technische Universität Chemnitz - Institut für Psychologie

🇩🇪

Chemnitz, Saxony, Germany

Thoraxklinik Heidelberg

🇩🇪

Heidelberg, Baden-Württemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath